Search Results

Filter
  • 1-10 of  6,036 results for ""Deoxycytidine""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Pyrvinium Pamoate Alone and With Gemcitabine Exhibits Anti-Pancreatic Cancer Activity in 2D and 3D Cell Culture Models.

  • Authors : Serala K; Department of Human Biology, University of Cape Town, Observatory, Cape Town, South Africa.; Bai J

Subjects: Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/drug therapy ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/pathology ; Gemcitabine*

  • Source: Journal of cellular and molecular medicine [J Cell Mol Med] 2024 Dec; Vol. 28 (23), pp. e70222.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101083777 Publication Model: Print Cited Medium:

Record details

×
Report

A mild case of acute generalized exanthematous pustulosis caused by gemcitabine.

  • Authors : Yamashita A; Department of Dermatology, Hirosaki University Graduate School of Medicine, Aomori, Japan.; Fukui T

Subjects: Acute Generalized Exanthematous Pustulosis*/Acute Generalized Exanthematous Pustulosis*/Acute Generalized Exanthematous Pustulosis*/diagnosis ; Acute Generalized Exanthematous Pustulosis*/Acute Generalized Exanthematous Pustulosis*/Acute Generalized Exanthematous Pustulosis*/etiology ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/adverse effects

  • Source: The Journal of dermatology [J Dermatol] 2022 Aug; Vol. 49 (8), pp. e261-e263. Date of Electronic Publication: 2022 Apr 10.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Sequential P-GEMOX and radiotherapy for early-stage extranodal natural killer/T-cell lymphoma: A multicenter study.

  • Authors : Zhang Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Asparaginase/Asparaginase/Asparaginase/*therapeutic use ; Deoxycytidine/Deoxycytidine/Deoxycytidine/*analogs & derivatives gemcitabine-oxaliplatin regimen

  • Source: American journal of hematology [Am J Hematol] 2021 Nov 01; Vol. 96 (11), pp. 1481-1490. Date of Electronic Publication: 2021 Sep 13.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Characteristic distribution of maculopapular rash caused by gemcitabine-based chemotherapy.

  • Authors : Tohyama M; Departments of, Dermatology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.; Asagi A

Subjects: Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/adverse effects ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Exanthema*/Exanthema*/Exanthema*/chemically induced

  • Source: The Journal of dermatology [J Dermatol] 2021 Feb; Vol. 48 (2), pp. 215-218. Date of Electronic Publication: 2020 Nov 11.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Evaluation of ABC gene polymorphisms on the pharmacokinetics and pharmacodynamics of capecitabine in colorectal patients: Implications for dosing recommendations.

  • Authors : Sáez-Belló M; Foundation for the Promotion of Health and Biomedical Research of Valencia, Department of Pharmacy, Doctor Peset University Hospital, Valencia, Spain.; Mangas-Sanjuán V

Subjects: Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/drug therapy ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/genetics ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/therapeutic use

  • Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Mar; Vol. 87 (3), pp. 905-915. Date of Electronic Publication: 2020 Jul 08.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Design and fabrication of dual-targeted delivery system based on gemcitabine-conjugated human serum albumin nanoparticles.

  • Authors : Norouzi P; Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.; Amini M

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*chemistry ; Deoxycytidine/Deoxycytidine/Deoxycytidine/*analogs & derivatives ; Nanocapsules/Nanocapsules/Nanocapsules/*chemistry

  • Source: Chemical biology & drug design [Chem Biol Drug Des] 2020 Aug; Vol. 96 (2), pp. 745-757. Date of Electronic Publication: 2020 Apr 26.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101262549 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades.

  • Authors : Shi Y; Department of Medical Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.; Fan Y

Subjects: Drug Synergism*; AMP-Activated Protein Kinases/AMP-Activated Protein Kinases/AMP-Activated Protein Kinases/*metabolism ; Deoxycytidine/Deoxycytidine/Deoxycytidine/*analogs & derivatives

  • Source: Journal of cellular and molecular medicine [J Cell Mol Med] 2020 Jan; Vol. 24 (1), pp. 760-771. Date of Electronic Publication: 2019 Nov 25.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101083777 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Determinants of the interindividual variability in serum cytidine deaminase activity of patients with solid tumours.

  • Authors : Cohen R; Department of Medical Oncology, Cochin Hospital, Paris Descartes University, CARPEM, AP-HP, Paris, France.; Preta LH

Subjects: Biological Variation, Population*; Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/Antimetabolites, Antineoplastic/*therapeutic use ; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*blood

  • Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2019 Jun; Vol. 85 (6), pp. 1227-1238. Date of Electronic Publication: 2019 Jan 30.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium:

Record details

×
Report

A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies.

  • Authors : Nanni L; Institute of Hematology 'L. e A. Seràgnoli,', University of Bologna, Bologna, Italy.; Morigi A

Subjects: Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*administration & dosage ; Deoxycytidine/Deoxycytidine/Deoxycytidine/*analogs & derivatives ; Sezary Syndrome/Sezary Syndrome/Sezary Syndrome/*drug therapy

  • Source: Hematological oncology [Hematol Oncol] 2019 Apr; Vol. 37 (2), pp. 202-204. Date of Electronic Publication: 2019 Jan 30.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  6,036 results for ""Deoxycytidine""